Compare FT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FT | HUMA |
|---|---|---|
| Founded | 1988 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.6M | 182.6M |
| IPO Year | N/A | N/A |
| Metric | FT | HUMA |
|---|---|---|
| Price | $7.96 | $1.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $10.13 |
| AVG Volume (30 Days) | 63.0K | ★ 5.0M |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 7.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,571,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $698.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.97 | $0.91 |
| 52 Week High | $7.23 | $5.33 |
| Indicator | FT | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 53.63 | 40.84 |
| Support Level | $7.94 | $0.91 |
| Resistance Level | $8.07 | $1.17 |
| Average True Range (ATR) | 0.08 | 0.08 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 76.79 | 35.90 |
Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.